In Vitro Diagnostics Quality Control Market Analysis to 2022 Lead by - Abbott Laboratories, Bio-Rad Laboratories Inc., Helena Laboratories, Ortho Clinical Diagnostics Inc.

Global In Vitro Diagnostics (IVD) Quality Control Market: Snapshot

The increasing prominence of the in vitro diagnostics sector in healthcare and its growing use across a number of regions across the world has boosted demand from the global in vitro diagnostics quality control market. In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnoses offered by their use and are thus likely to remain in demand in the coming years. The global in vitro diagnostics quality control market is thus likely to exhibit a steady CAGR of 3.3% over the 2017-2022 forecast period.

Obtain Report Details @ https://www.transparencymarketresearch.com/in-vitro-diagnostics-quality-control-market.html

Transparency Market Research estimates the global in vitro diagnostics quality control market to rise to a valuation of US$710.8 mn by the end of 2017 and further rise to US$837 mn by the end of 2022. The steady rise in investment in the healthcare sector in recent years from governments as well as leading private sector players is likely to aid smooth growth of the in vitro diagnostics quality control market in the coming years.

Whole Blood Based Controls Set to Dominate Global In Vitro Diagnostics Quality Control Market

The report segments the global in vitro diagnostics quality control market by product type into whole blood based controls, serum/plasma based controls, urine based controls, data management solutions, quality assurance services, and others. Of these, whole blood based controls are likely to dominate the global in vitro diagnostics quality control market in the coming years due to the comprehensive assessment they provide in in vitro diagnostics.

The whole blood based controls segment of the global in vitro diagnostics quality control market is expected to be valued at US$208.5 mn by the end of 2017 and further rise to US$238.5 mn by the end of 2022. The segment’s 2.7% CAGR over the 2017-2022 forecast period is likely to lead to its share in the market dropping from 29.3% to 28.5% by 2022, but its annual growth figure of US$6 mn is the highest in the global in vitro diagnostics quality control market.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33194

North America to Remain Most Promising Region for In Vitro Diagnostics Quality Control Market

The North America market for in vitro diagnostics quality controls is expected to rise from US$262.8 mn in 2017 to US$311.7 mn by the end of 2022. North America accounted for close to 37% of the global in vitro diagnostics quality control market in 2017 and is likely to remain similarly dominant in the global figures over the 2017-2022 forecast period. The North America in vitro diagnostics quality control market is likely to exhibit a strong 3.5% CAGR between 2017 and 2022 to remain the most attractive region for in vitro diagnostics quality control market players.

APEJ to Match North America’s CAGR, to Rise to US$136 mn by 2022

Despite North America’s dominance in the in vitro diagnostics quality control market, Asia Pacific except Japan is also likely to play a prominent role in the development of the global in vitro diagnostics quality control market in the coming years. The Asia Pacific except Japan in vitro diagnostics quality control market is expected to exhibit a strong 3.5% CAGR over the 2017-2022 forecast period, rising to a valuation of US$136 mn by the end of 2022.

In Vitro Diagnostics (IVD) Quality Control Market: Competitive Dynamics

Key players in the global in vitro diagnostics quality control market include Abbott Laboratories, Bio-Rad Laboratories Inc., Helena Laboratories, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Diagnostics, Seracare Life Sciences Inc., Siemens Healthineers, Sun Diagnostics LLC, Thermo Fisher Scientific Inc., Sysmex Corporation, and Quantimetrix Corporation.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.